Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Process Safety Guide Helps Scientists Reduce Runaway Reaction Risk

Published: Monday, October 08, 2012
Last Updated: Monday, October 08, 2012
Bookmark and Share
New Guide to increase process safety, limit rework, and lower related manufacturing costs.

A new, free METTLER TOLEDO Process Safety Guide entitled “Understanding the Risks: Safe Chemical Processes at Scale” helps chemists and engineers mitigate a given experiment’s runaway reaction risk to promote safer manufacturing.

Even though chemical manufacturing should be intrinsically safe, the Guide shows how appropriate process review is essential to maintaining reaction control, particularly when operating conditions deviate from expected norms.

Predominant variables discussed include reactant accumulation, high impurity sensitivity, induction issues and inaccurate kinetic assumptions.

Modeling for heat, energy accumulation, and induction is covered in depth using a semi-batch nitration reaction as an example.

Because modeling reactions in practice is typically not feasible, the Guide shows how critical process safety analysis can be reduced to a number of basic properties that accurately predict maximum temperature of the synthesis reaction (MTSR) and worst-case scenario maximum attainable temperature (MAT).

This data, in turn, can be depicted as a “Runaway Graph,” accounting for both primary and secondary reactions. This graph can then be used to effectively redesign processes to increase reaction safety, even under unexpected, adverse conditions, using techniques such as modifying concentration/feed rates and continuous vs. batch or semi-batch processing. Evaluating process criticality is also covered.

The ultimate goal of the Process Safety Guide is to achieve desired reaction outcomes-including maximum productivity-alongside optimum safety.

To learn more about effectively modeling potential runaway scenarios, and how applying these models to chemical and pharmaceutical manufacturing can help limit manufacturing hazards and reduce costs, download a copy of the Guide free at www.mt.com/AC-PSGuide.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

13 Ways to Stop an Unseen Force from Disrupting Weighing
Download a free Mettler Toledo paper to discover how to halt static’s negative effects before the next weigh-in.
Saturday, October 03, 2015
Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Scientific News
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Immunotherapy Reduces Rheumatoid-Linked Cardiovascular Risk
Study shows combination of two extra-low dose anticytokines reduces disease activity and cardiovascular events.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
Sanofi Working on Zika Vaccine with U.S. Army
Sanofi is working in conjunction with the U.S. Army to develop possible Zika vaccine at faster rate following research agreement.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!